Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2010 | 03-2010 | 03-2009 | 03-2008 | 03-2007 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 10,240 | 51,400 | N/A | N/A |
| Depreciation Amortization | N/A | 4,580 | 23,000 | N/A | N/A |
| Other Working Capital | N/A | -1,620 | 13,470 | N/A | N/A |
| Other Operating Activity | 0 | 2,640 | -13,810 | 0 | 0 |
| Operating Cash Flow | $N/A | $15,840 | $74,060 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -510 | -3,430 | N/A | N/A |
| Other Investing Activity | 0 | -11,180 | -6,620 | 0 | 0 |
| Investing Cash Flow | $N/A | $-11,690 | $-10,050 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 2,280 | -29,100 | 0 | 0 |
| Financing Cash Flow | $N/A | $2,280 | $-29,100 | $N/A | $N/A |
| Exchange Rate Effect | N/A | -90 | -2,030 | N/A | N/A |
| Beginning Cash Position | N/A | 98,430 | 45,170 | N/A | N/A |
| End Cash Position | N/A | 104,780 | 78,050 | N/A | N/A |
| Net Cash Flow | $N/A | $6,340 | $32,870 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 15,840 | 74,060 | N/A | N/A |
| Free Cash Flow | 0 | 15,840 | 74,060 | 0 | 0 |